Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Electromyographic Biofeedback for Dysfunctional Voiding in Children and Adolescents: A Systematic Review and Meta-analysis of Randomized Trials.

Urology·2025
Same author

Prophylactic anticoagulants for people hospitalized with COVID-19: systematic review.

The British journal of surgery·2021
Same author

Minoxidil for patchy alopecia areata: systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2014
Same author

Treatment for agenesis of maxillary lateral incisors: a systematic review.

Orthodontics & craniofacial research·2013
Same author

Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2008

Related Experiment Video

Updated: Jul 12, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

Thyroid hormone replacement for subclinical hypothyroidism.

H C C E Villar1, H Saconato, O Valente

  • 1Faculdade Estadual de Medicina de Marília, Departamento de Medicina Interna, Av. Cascata 123, Marília, São Paulo, Brazil, 17515-300. hvillar@famema.br

The Cochrane Database of Systematic Reviews
|July 20, 2007
PubMed
Summary

Thyroid hormone replacement for subclinical hypothyroidism did not improve survival or cardiovascular health. While some lipid profiles and heart function showed minor improvements, quality of life and symptoms did not significantly change.

More Related Videos

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Related Experiment Videos

Last Updated: Jul 12, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Area of Science:

  • Endocrinology
  • Internal Medicine

Background:

  • Subclinical hypothyroidism, characterized by elevated TSH with normal thyroid hormones, affects 4-8% of the general population.
  • Prevalence increases to 15-18% in women over 60, with ongoing debate about treatment necessity and clinical significance.

Purpose of the Study:

  • To evaluate the effects of thyroid hormone replacement therapy in individuals with subclinical hypothyroidism.

Main Methods:

  • Systematic review of 12 randomized controlled trials (RCTs) involving 350 adults with subclinical hypothyroidism.
  • Trials compared levothyroxine replacement with placebo or no treatment, with a minimum follow-up of one month.

Main Results:

  • No significant improvements in survival or cardiovascular morbidity were observed.
  • No statistically significant differences in quality of life or symptoms were found, though one study noted improved cognitive function.
  • Trends suggested improvements in lipid profiles and echocardiographic parameters, including myocardial relaxation and diastolic function.

Conclusions:

  • Current RCTs indicate levothyroxine replacement does not enhance survival or reduce cardiovascular morbidity in subclinical hypothyroidism.
  • No significant impact on health-related quality of life or symptoms was demonstrated.
  • Evidence suggests potential benefits for lipid profiles and left ventricular function.